Importantly, TNF/Mel/SM treatment caused an increase in immune infiltration of BN175 sarcoma, leading to elevated levels of T cells (Fig 4B) and natural killer (NK) cells (Fig 4C). This evidence concerns the gene TNF and sarcoma.